Animal Parasiticides

Animal Parasiticides

Animal Parasiticides market worldwide is projected to grow by US$3.3 Billion, driven by a compounded growth of 5.2%. Ectoparasiticides, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$4.1 Billion by the year 2025, Ectoparasiticides will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 5.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$163 Million to the region's size and clout in the next 5 to 6 years. Over US$198.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Ectoparasiticides will reach a market size of US$139.2 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.2% over the next couple of years and add approximately US$372.4 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Bayer AG; Boehringer Ingelheim International GmbH; Ceva Santé Animale; Elanco Animal Health; Merck Animal Health; PetIQ; Vétoquinol SA; Virbac SA; Zoetis, Inc.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.